主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ALUR-WT
#4094
Allurion Technologies, Inc.
0.016
0
-46.31%
版块:
基础:
利润货币:
日范围
年范围
日变化
-46.31%
每月变动
-20.00%
6个月变化
-40.74%
年变化
-58.44%
前一天收盘价
0.029
8
Open
0.017
0
Bid
Ask
Low
0.016
0
High
0.017
0
交易量
5
市场
股票
ALUR-WT
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2023
2024
TTM
Key stats
Total common shares outstanding
1.91 M
5.96 M
—
Valuation ratios
Enterprise value
—
—
—
Price to earnings ratio
-0.01
-0
-0.01
Price to sales ratio
0.01
0
0.02
Price to cash flow ratio
0.01
0
0.01
Price to book ratio
0.01
0
0
Enterprise value to EBITDA ratio
—
—
—
Profitability ratios
Return on assets %
1.12
0.8
1.39
Return on equity %
1.14
0.34
0.49
Return on invested capital %
587.6
608.85
1 907.28
Gross margin %
77.61
66.97
242.83
Operating margin %
147.9
156.33
1 004.77
EBITDA margin %
-144.24
-148.99
-977.44
Net margin %
150.76
81.43
982.49
Liquidity ratios
Quick ratio
0.9
1.26
5.77
Current ratio
0.99
1.44
6.8
Inventory turnover
0.23
0.47
0.44
Asset turnover
0.75
0.61
0.51
Solvency ratios
Debt to assets ratio
—
—
—
Debt to equity ratio
—
—
—
Long term debt to total assets ratio
0.54
1.09
4.69
Long term debt to total equity ratio
0.55
0.46
1.74
Per share metrics
Operating cash flow per share
44.97
18.82
9.38
EBIT per share
-55.56
-22.34
-11.02
EBITDA per share
-54.19
-21.29
-10.82
Total debt per share
—
—
—
Cash per share
26.73
6.84
12.77
Net current asset value per share
45.54
12.08
22.69
Tangible book value per share
49.52
34.7
65.74
Working capital per share
-0.43
3.69
8.57
Book value per share
49.52
34.7
65.74
新闻
Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?
Allurion Technologies修改权证条款并通过诱导要约筹集300万美元
What's Going On With Allurion Stock On Wednesday? - Allurion Technologies (NYSE:ALUR)
Allurion Technologies股票评级因FDA批准而上调
Allurion Technologies stock rating upgraded on FDA approval
Allurion股价飙升40%,获美国FDA批准
FDA approves Allurion gastric balloon for obesity treatment
Allurion stock surges 40% on U.S. FDA approval
Tracking Saudi Sovereign Wealth Fund’s 13F Portfolio – Q3 2025 Update
Allurion Technologies (ALUR)董事出售价值4.9千美元股票
Allurion Technologies (ALUR) director sells $4.9k in shares
Allurion reports 23% weight loss combining balloon with low-dose GLP-1